ResMed (RMD) Tops Q2 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. CSX
7. LRCX
8. MRK
9. LVS
10. SAP

Go back to ResMed (RMD) Tops Q2 EPS by 3c

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2016

January 21, 2016 4:05 PM EST

SAN DIEGO, Jan. 21, 2016 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced results for its quarter ended December 31, 2015. Revenue for the quarter was $454.5 million, a 7 percent increase compared with the quarter ended December 31, 2014; this is a 13 percent increase on a constant currency basis.  

"We remain focused on delivering strong long-term growth from our sleep-disordered breathing and respiratory care businesses.  Our team continued to deliver double-digit constant currency growth this quarter," said Mick Farrell, ResMed's chief executive officer. "Our Americas region was a significant contributor this quarter, as our customers continued to... More